Oral Care Product Development and Trial Management Benchmarking Survey Open

Product Development and Clinical Trial Study Looks at Costs, Strategy and Tactics, According to Cutting Edge Information


DURHAM, NC--(Marketwire - March 31, 2010) -  Business research firm Cutting Edge Information has launched an in-depth study focused on budgeting and management for oral care product development and clinical trials (http://www.cuttingedgeinfo.com/surveys/oralcare/oralcare.htm).

Cutting Edge Information analysts built this study's framework from the topics most important to product development executives during the development phase. "This study will allow consumer product organizations to benchmark their efforts against top performers and incorporate best practices into their departments," said Yanis Saradjian, director of consulting.

Saradjian intends the study to provide partners with key insights and tactical opportunities for both new products and expanded uses for existing products. All dental care and oral health professionals interested in product development, clinical development and clinical trials can participate in the study at http://www.cuttingedgeinfo.com/surveys/oralcare/oralcare.htm.

"As the science of dental and oral care advances and the marketplace becomes more complex, every company must continuously improve the management and strategy for their product development efforts," said Adam Bianchi, chief operating officer at Cutting Edge Information. "Consumer goods companies now need to systematically manage product development in a global context to ensure effective marketing, regulatory compliance, product launch, competitive market positioning, lifecycle management and revenue maximization."

According to Bianchi, oral care Consumer Packaged Goods leaders such as Blistex, C.B. Fleet, Chattem, Colgate-Palmolive, Church & Dwight, Del Laboratories, GABA, GlaxoSmithKline, Johnson & Johnson, Kimberly-Clarke, Millennium Dental, Pfizer, Philips Healthcare, Procter & Gamble, Reckitt-Benckiser, S.C. Johnson & Sons and Unilever have all recently fine-tuned their product development strategies and processes. 

"But moving from the art of product development to a true science of trial management is a work in progress," Bianchi said. "This study will help every participant understand the industry's baseline best practices as well as truly cutting-edge next practices." 

Contact Information:

For more information about the study or to participate as a benchmark partner, please contact
Yanis Saradjian at +1-919-433-0206 or .